SF3B1 and myelodysplastic syndrome: Recently, the 5th WHO changed the classification of MDS by defining genetic abnormalities, identifying MDS with low blasts and SF3B1 mutation (MDS-SF3B1) as a distinct disease type that includes most MDS with ≥5% RS.